Regular Article| Volume 8, ISSUE 4, P253-254, June 1999

Download started.


Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

      This paper is only available as a PDF. To read, Please Download here.




        • Lindhout D.
        • Meinardi H.
        Spina bifida and in utero exposure to valproate.
        Lancet. 1994; 343: 396
        • MRC Vitamin Study Research Group
        Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
        Lancet. 1991; 338: 131-137
        • Clayton-Smith J.
        • Donnai D.
        Fetal valproate syndrome.
        Journal of Medical Genetics. 1995; 32: 724-727
        • Van Allen M.I.
        • Kalousek D.K.
        • Chernoff G.F.
        • et al.
        Evidence for multi-site closure of the neural tube in humans.
        American Journal of Medical Genetics. 1993; 47: 723-743
        • Trotz M.
        • Wegner S.
        • Nau H.
        Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse.
        Life Sciences. 1987; 41: 103-110
        • Elmazar M.M.A.
        • Thiel T.
        • Nau H.
        Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
        Fundamental Applied Toxicology. 1992; 18: 389-394
        • Essien F.B.
        • Wannberg S.L.
        Methionine but not folinic acid or vitamin B12 alters the frequency of neural tube defects in Axd mutant mice.
        Journal of Nutrition. 1993; 123: 27-34
        • Hansen D.K.
        • Grafton T.F.
        • Dial S.L.
        • Gehring T.A.
        • Sitonen P.H.
        Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
        Teratology. 1995; 52: 277-285
        • Dansky L.V.
        • Rosenblatt D.A.
        • Andermann E.
        Mechanisms of teratogenesis: folic acid and antiepileptic therapy.
        Neurology. 1992; 42 (Suppl. 5): 32-42
        • Kishi T.
        • Fujita N.
        • Eguchi T.
        • Ueda K.
        Mechanism for the reduction of serum folate by antiepileptic drugs during prolonged therapy.
        Journal of Neurological Science. 1997; 145: 109-112
        • Centers for Disease Control
        Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.
        Morbidity Mortality Weekly Report. 1992; 41: 1-7
        • Werler M.W.
        • Schapiro S.
        • Mitchell A.A.
        Periconceptual folic acid exposure and risk of occurrent neural-tube defects.
        Journal of the American Medical Association. 1993; 269: 1257-1261
        • Daly S.
        • Mills J.L.
        • Molloy A.M.
        • et al.
        Minimum effective dose of folic acid for food fortification to prevent neural tube defects.
        Lancet. 1997; 350: 1666-1669
        • Czeizel A.E.
        • Dudas I.
        Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation.
        New England Journal of Medicine. 1992; 327: 1832-1835